Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 266 | 3 | NUCL MED//RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING//JOURNAL OF NUCLEAR MEDICINE | 45145 |
| 396 | 2 | RADIOIMMUNOTHERAPY//NUCLEAR MEDICINE AND BIOLOGY//RADIOPHARMACEUTICALS | 17258 |
| 19515 | 1 | PRETARGETING//PRETARGETED RADIOIMMUNOTHERAPY//AVIDINOX | 526 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | PRETARGETING | authKW | 3135033 | 17% | 59% | 88 |
| 2 | PRETARGETED RADIOIMMUNOTHERAPY | authKW | 618081 | 3% | 74% | 14 |
| 3 | AVIDINOX | authKW | 299584 | 1% | 100% | 5 |
| 4 | MOL MED IMMUNOL | address | 183273 | 4% | 16% | 19 |
| 5 | MULTISTEP TARGETING | authKW | 179750 | 1% | 100% | 3 |
| 6 | PRIT | authKW | 179750 | 1% | 100% | 3 |
| 7 | RADIOIMMUNOTHERAPY | authKW | 173251 | 12% | 5% | 61 |
| 8 | ANTISENSE IMAGING | authKW | 159775 | 1% | 67% | 4 |
| 9 | BISPECIFIC ANTIBODY | authKW | 143508 | 6% | 8% | 29 |
| 10 | UNIT 463 | address | 136169 | 1% | 45% | 5 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Radiology, Nuclear Medicine & Medical Imaging | 5572 | 40% | 0% | 210 |
| 2 | Oncology | 1127 | 25% | 0% | 133 |
| 3 | Biochemical Research Methods | 732 | 13% | 0% | 69 |
| 4 | Chemistry, Organic | 313 | 12% | 0% | 65 |
| 5 | Medicine, Research & Experimental | 242 | 9% | 0% | 48 |
| 6 | Pharmacology & Pharmacy | 202 | 14% | 0% | 72 |
| 7 | Chemistry, Multidisciplinary | 151 | 14% | 0% | 72 |
| 8 | Biochemistry & Molecular Biology | 122 | 17% | 0% | 88 |
| 9 | Chemistry, Medicinal | 31 | 3% | 0% | 16 |
| 10 | Hematology | 15 | 2% | 0% | 13 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | MOL MED IMMUNOL | 183273 | 4% | 16% | 19 |
| 2 | UNIT 463 | 136169 | 1% | 45% | 5 |
| 3 | MOL PHARMACOL THER Y SERV | 134811 | 1% | 75% | 3 |
| 4 | GARDEN STATE CANC | 122682 | 3% | 13% | 16 |
| 5 | ABT RADIOCHEM RADIOPHARMAKOL | 59917 | 0% | 100% | 1 |
| 6 | BOUVE HLTH SCI PHARMACEUT SCI | 59917 | 0% | 100% | 1 |
| 7 | CEA LRC | 59917 | 0% | 100% | 1 |
| 8 | CHEM BIOL PEPTIDES PROT | 59917 | 0% | 100% | 1 |
| 9 | CRCNAINSERMUMR892 | 59917 | 0% | 100% | 1 |
| 10 | DAHFMO UNIT HISTOL MED EMBIYOL | 59917 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BIOCONJUGATE CHEMISTRY | 36240 | 11% | 1% | 56 |
| 2 | JOURNAL OF NUCLEAR MEDICINE | 27696 | 13% | 1% | 69 |
| 3 | CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 27353 | 5% | 2% | 26 |
| 4 | NUCLEAR MEDICINE AND BIOLOGY | 20809 | 7% | 1% | 36 |
| 5 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 6423 | 4% | 1% | 19 |
| 6 | ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS | 5838 | 1% | 2% | 4 |
| 7 | MOLECULAR IMAGING AND BIOLOGY | 4699 | 2% | 1% | 9 |
| 8 | NUCLEAR MEDICINE COMMUNICATIONS | 3599 | 3% | 0% | 16 |
| 9 | CLINICAL CANCER RESEARCH | 2420 | 5% | 0% | 25 |
| 10 | QUARTERLY JOURNAL OF NUCLEAR MEDICINE | 1183 | 0% | 1% | 2 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PRETARGETING | 3135033 | 17% | 59% | 88 | Search PRETARGETING | Search PRETARGETING |
| 2 | PRETARGETED RADIOIMMUNOTHERAPY | 618081 | 3% | 74% | 14 | Search PRETARGETED+RADIOIMMUNOTHERAPY | Search PRETARGETED+RADIOIMMUNOTHERAPY |
| 3 | AVIDINOX | 299584 | 1% | 100% | 5 | Search AVIDINOX | Search AVIDINOX |
| 4 | MULTISTEP TARGETING | 179750 | 1% | 100% | 3 | Search MULTISTEP+TARGETING | Search MULTISTEP+TARGETING |
| 5 | PRIT | 179750 | 1% | 100% | 3 | Search PRIT | Search PRIT |
| 6 | RADIOIMMUNOTHERAPY | 173251 | 12% | 5% | 61 | Search RADIOIMMUNOTHERAPY | Search RADIOIMMUNOTHERAPY |
| 7 | ANTISENSE IMAGING | 159775 | 1% | 67% | 4 | Search ANTISENSE+IMAGING | Search ANTISENSE+IMAGING |
| 8 | BISPECIFIC ANTIBODY | 143508 | 6% | 8% | 29 | Search BISPECIFIC+ANTIBODY | Search BISPECIFIC+ANTIBODY |
| 9 | TUMOR PRETARGETING | 134811 | 1% | 75% | 3 | Search TUMOR+PRETARGETING | Search TUMOR+PRETARGETING |
| 10 | ANTIBODY PRETARGETING | 119834 | 0% | 100% | 2 | Search ANTIBODY+PRETARGETING | Search ANTIBODY+PRETARGETING |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |